Delphi consensus recommendation for optimization of pulmonary hypertension therapy focusing on switching from a phosphodiesterase 5 inhibitor to riociguat.
Saved in:
| Title: | Delphi consensus recommendation for optimization of pulmonary hypertension therapy focusing on switching from a phosphodiesterase 5 inhibitor to riociguat. |
|---|---|
| Authors: | Rahaghi, Franck F.1 rahaghf@ccf.org, Balasubramanian, Vijay P.2, Bourge, Robert C.3, Burger, Charles D.4, Chakinala, Murali M.5, Eggert, Michael S.6, Elwing, Jean M.7, Feldman, Jeremy8, King, Christopher9, Klinger, James R.10, Mathai, Stephen C.11, McConnell, John Wesley12, Palevsky, Harold I.13, Restrepo‐Jaramillo, Ricardo14, Safdar, Zeenat15, Sager, Jeffrey S.16, Sood, Namita17, Sulica, Roxana18, James White, R.19, Hill, Nicholas S.20 |
| Source: | Pulmonary Circulation. Apr2022, Vol. 12 Issue 2, p1-13. 13p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
